CNS Pharmaceuticals, Inc.

NEWS

Image of Houston downtown park and skyline in the morning

Business

Houston’s Life Sciences Scene Continues Boosting Its Reputation

While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.

March 13, 2025

6 min read

Angela Gabriel

IN THE PRESS

Deals

CNS Pharmaceuticals Announces Reverse Stock Split - June 4, 2024

June 3, 2024

3 min read

Lone Star Bio

CNS Pharmaceuticals to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase

May 20, 2024

1 min read

Business

CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

May 16, 2024

5 min read

Lone Star Bio

CNS Pharmaceuticals to Present at the LSX World Congress 2024

April 23, 2024

2 min read

Lone Star Bio

CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity

April 22, 2024

1 min read

Business

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

April 1, 2024

8 min read

Lone Star Bio

CNS Pharmaceuticals to Present at Two Investor Conferences in April 2024

April 1, 2024

1 min read

Lone Star Bio

CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering

January 29, 2024

5 min read

Business

Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors

January 18, 2024

5 min read

Lone Star Bio

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

January 17, 2024

5 min read

JOBS